Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.

Schizophrenia and schizophrenia-like symptoms induced by the dopamine agonists and N-methyl-D aspartate type glutamate receptor antagonists occur only after the adolescent period. Similarly, animal models of schizophrenia by these drugs are also induced after the critical period around postnatal wee...

全面介绍

书目详细资料
Main Authors: Momoko Kobayashi, Daisuke Jitoku, Yoshimi Iwayama, Naoki Yamamoto, Tomoko Toyota, Katsuaki Suzuki, Mitsuru Kikuchi, Tasuku Hashimoto, Nobuhisa Kanahara, Akeo Kurumaji, Takeo Yoshikawa, Toru Nishikawa
格式: 文件
语言:English
出版: Public Library of Science (PLoS) 2018-01-01
丛编:PLoS ONE
在线阅读:http://europepmc.org/articles/PMC5757935?pdf=render
_version_ 1831620806821543936
author Momoko Kobayashi
Daisuke Jitoku
Yoshimi Iwayama
Naoki Yamamoto
Tomoko Toyota
Katsuaki Suzuki
Mitsuru Kikuchi
Tasuku Hashimoto
Nobuhisa Kanahara
Akeo Kurumaji
Takeo Yoshikawa
Toru Nishikawa
author_facet Momoko Kobayashi
Daisuke Jitoku
Yoshimi Iwayama
Naoki Yamamoto
Tomoko Toyota
Katsuaki Suzuki
Mitsuru Kikuchi
Tasuku Hashimoto
Nobuhisa Kanahara
Akeo Kurumaji
Takeo Yoshikawa
Toru Nishikawa
author_sort Momoko Kobayashi
collection DOAJ
description Schizophrenia and schizophrenia-like symptoms induced by the dopamine agonists and N-methyl-D aspartate type glutamate receptor antagonists occur only after the adolescent period. Similarly, animal models of schizophrenia by these drugs are also induced after the critical period around postnatal week three. Based upon the development-dependent onsets of these psychotomimetic effects, by using a DNA microarray technique, we identified the WD repeat domain 3 (WDR3) and chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) genes as novel candidates for schizophrenia-related molecules, whose mRNAs were up-regulated in the adult (postnatal week seven), but not in the infant (postnatal week one) rats by an indirect dopamine agonist, and phencyclidine, an antagonist of the NMDA receptor. WDR3 and other related proteins are the nuclear proteins presumably involved in various cellular activities, such as cell cycle progression, signal transduction, apoptosis, and gene regulation. ALG1 is presumed to be involved in the regulation of the protein N-glycosylation. To further elucidate the molecular pathophysiology of schizophrenia, we have evaluated the genetic association of WDR3 and ALG1 in schizophrenia. We examined 21 single nucleotide polymorphisms [SNPs; W1 (rs1812607)-W16 (rs6656360), A1 (rs8053916)-A10 (rs9673733)] from these genes using the Japanese case-control sample (1,808 schizophrenics and 2,170 matched controls). No significant genetic associations of these SNPs were identified. However, we detected a significant association of W4 (rs319471) in the female schizophrenics (allelic P = 0.003, genotypic P = 0.008). Based on a haplotype analysis, the observed haplotypes consisting of W4 (rs319471)-W5 (rs379058) also displayed a significant association in the female schizophrenics (P = 0.016). Even after correction for multiple testing, these associations remained significant. Our findings suggest that the WDR3 gene may likely be a sensitive factor in female patients with schizophrenia, and that modification of the WDR3 signaling pathway warrants further investigation as to the pathophysiology of schizophrenia.
first_indexed 2024-12-18T21:18:20Z
format Article
id doaj.art-901b6e3248ba490b9ffccaf213e9fa91
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-18T21:18:20Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-901b6e3248ba490b9ffccaf213e9fa912022-12-21T20:52:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01131e019099110.1371/journal.pone.0190991Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.Momoko KobayashiDaisuke JitokuYoshimi IwayamaNaoki YamamotoTomoko ToyotaKatsuaki SuzukiMitsuru KikuchiTasuku HashimotoNobuhisa KanaharaAkeo KurumajiTakeo YoshikawaToru NishikawaSchizophrenia and schizophrenia-like symptoms induced by the dopamine agonists and N-methyl-D aspartate type glutamate receptor antagonists occur only after the adolescent period. Similarly, animal models of schizophrenia by these drugs are also induced after the critical period around postnatal week three. Based upon the development-dependent onsets of these psychotomimetic effects, by using a DNA microarray technique, we identified the WD repeat domain 3 (WDR3) and chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) genes as novel candidates for schizophrenia-related molecules, whose mRNAs were up-regulated in the adult (postnatal week seven), but not in the infant (postnatal week one) rats by an indirect dopamine agonist, and phencyclidine, an antagonist of the NMDA receptor. WDR3 and other related proteins are the nuclear proteins presumably involved in various cellular activities, such as cell cycle progression, signal transduction, apoptosis, and gene regulation. ALG1 is presumed to be involved in the regulation of the protein N-glycosylation. To further elucidate the molecular pathophysiology of schizophrenia, we have evaluated the genetic association of WDR3 and ALG1 in schizophrenia. We examined 21 single nucleotide polymorphisms [SNPs; W1 (rs1812607)-W16 (rs6656360), A1 (rs8053916)-A10 (rs9673733)] from these genes using the Japanese case-control sample (1,808 schizophrenics and 2,170 matched controls). No significant genetic associations of these SNPs were identified. However, we detected a significant association of W4 (rs319471) in the female schizophrenics (allelic P = 0.003, genotypic P = 0.008). Based on a haplotype analysis, the observed haplotypes consisting of W4 (rs319471)-W5 (rs379058) also displayed a significant association in the female schizophrenics (P = 0.016). Even after correction for multiple testing, these associations remained significant. Our findings suggest that the WDR3 gene may likely be a sensitive factor in female patients with schizophrenia, and that modification of the WDR3 signaling pathway warrants further investigation as to the pathophysiology of schizophrenia.http://europepmc.org/articles/PMC5757935?pdf=render
spellingShingle Momoko Kobayashi
Daisuke Jitoku
Yoshimi Iwayama
Naoki Yamamoto
Tomoko Toyota
Katsuaki Suzuki
Mitsuru Kikuchi
Tasuku Hashimoto
Nobuhisa Kanahara
Akeo Kurumaji
Takeo Yoshikawa
Toru Nishikawa
Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
PLoS ONE
title Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
title_full Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
title_fullStr Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
title_full_unstemmed Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
title_short Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.
title_sort association studies of wd repeat domain 3 and chitobiosyldiphosphodolichol beta mannosyltransferase genes with schizophrenia in a japanese population
url http://europepmc.org/articles/PMC5757935?pdf=render
work_keys_str_mv AT momokokobayashi associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT daisukejitoku associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT yoshimiiwayama associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT naokiyamamoto associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT tomokotoyota associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT katsuakisuzuki associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT mitsurukikuchi associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT tasukuhashimoto associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT nobuhisakanahara associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT akeokurumaji associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT takeoyoshikawa associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation
AT torunishikawa associationstudiesofwdrepeatdomain3andchitobiosyldiphosphodolicholbetamannosyltransferasegeneswithschizophreniainajapanesepopulation